Engineers Gate Manager LP Beyond Spring Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.13 - $2.66 $14,031 - $33,029	12,417 New	12,417 $18,000
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $136,699 - $407,658	-81,369 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $327,103 - $1.37 Million	81,369 New	81,369 $369,000
Q2 2021 Aug 16, 2021	SELL	$9.37 - $12.12 $125,295 - $162,068	-13,372 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.61 - $15.77 $100,667 - $149,625	-9,488 Reduced 41.5%	13,372 $148,000
Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $233,400 - $395,706	22,860 New	22,860 $279,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $68.1M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.